These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 459082)

  • 21. [Profile of cefmetazole. Report IV. In the field of surgery (author's transl)].
    Shibata K
    Kansenshogaku Zasshi; 1979 Feb; 53(2):82-6. PubMed ID: 115939
    [No Abstract]   [Full Text] [Related]  

  • 22. [Experimental and clinical studies of cefmetazole in the field of oral surgery].
    Minami Y; Taguchi M; Nanba R; Tsuto H; Yamamoto T; Ueda K; Tsushima T; Morihana T; Nagata K; Nakao K; Shimada K
    Jpn J Antibiot; 1982 May; 35(5):1308-21. PubMed ID: 6957626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of cephamycins in obstetrics and gynecology.
    Sweet RL
    J Reprod Med; 1990 Nov; 35(11 Suppl):1064-9. PubMed ID: 2277374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical chemotherapy with a new cephalosporin: cephalexin].
    Lamanna A; Gerli P; Periti P; Tomarchio C; Zucconi G
    Riv Ostet Ginecol; 1969 Dec; 24(12):399-411. PubMed ID: 5404220
    [No Abstract]   [Full Text] [Related]  

  • 25. [Fundamental and clinical studies on CS-1170 (author's transl)].
    Motohiro T; Sakata Y; Nishiyama T; Ishimoto K; Tominaga K; Yamashita F
    Jpn J Antibiot; 1979 Feb; 32(2):195-204. PubMed ID: 439391
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cefotetan, a new cephamycin antibiotic: in vitro and in vivo antibacterial activities (author's transl)].
    Yano K; Suzaki K; Saito M; Toda M; Naito S; Ohmi Y
    Jpn J Antibiot; 1982 Feb; 35(2):438-59. PubMed ID: 6953260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of CS-1170 in pediatric field (author's transl)].
    Iwai N; Sasaki A; Futamura J; Miyatsu M; Osuga T
    Jpn J Antibiot; 1979 Feb; 32(2):205-20. PubMed ID: 439392
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical studies of 6059-S in the field of pediatrics (author's transl)].
    Minamitani M; Hachimori K; Tomori N
    Jpn J Antibiot; 1981 Apr; 34(4):608-17. PubMed ID: 6457169
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical evaluation of cefmetazole in the dermatologic field].
    Asada Y; Nishijima S; Ozaki M; Sotomatsu S; Kishimoto S; Sugai T; Hayakawa M; Soh Y; Doi A; Higashi N; Uragami K
    Jpn J Antibiot; 1982 Jun; 35(6):1493-510. PubMed ID: 6752465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A study of safety of cefmetazole (CS-1170) in pregnant women during the perinatal stage (author's transl)].
    Jpn J Antibiot; 1981 Jun; 34(6):907-14. PubMed ID: 6945451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Laboratory and clinical studies on 6059-S in children (author's transl)].
    Iwai N; Sasaki A; Taneda Y; Osuga T; Inokuma K
    Jpn J Antibiot; 1981 May; 34(5):782-99. PubMed ID: 6457176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacokinetics, in vitro activity and clinical experience with lamoxactam].
    Klech H; Fiser I
    Schweiz Rundsch Med Prax; 1983 Mar; 72(11):369-78. PubMed ID: 6221244
    [No Abstract]   [Full Text] [Related]  

  • 33. [A study on cefmetazole in the neonatal period (author's transl)].
    Iwai N; Sasaki A; Taneda Y; Inokuma K
    Jpn J Antibiot; 1981 Jun; 34(6):881-92. PubMed ID: 6945448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical effectiveness of CS-1170 in the pediatric field (author's transl)].
    Minamitani M; Hachimori K; Tomori N
    Jpn J Antibiot; 1979 Feb; 32(2):241-6. PubMed ID: 439396
    [No Abstract]   [Full Text] [Related]  

  • 35. [Review [new antibiotics series IV]: latamoxef (author's transl)].
    Matsumoto K
    Jpn J Antibiot; 1982 Mar; 35(3):704-13. PubMed ID: 6212703
    [No Abstract]   [Full Text] [Related]  

  • 36. [Laboratory and clinical studies of cefmetazole in serious infection by Staphylococcus (author's transl)].
    Motohiro T; Sakata Y; Fujimoto T; Nishiyama T; Ishimoto K; Tominaga K; Yamashita F; Onoda Y; Kusayanagi T; Tsuboi M; Toubo Y; Yamamoto M; Komatsu R; Tanaka C; Baba Y
    Jpn J Antibiot; 1982 Mar; 35(3):821-34. PubMed ID: 6954289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Massive cefmetazole (CS-1170) therapy for extremely severe respiratory infections (author's transl)].
    Isawa T; Teshima T; Hirano T; Ebina A; Konno K
    Jpn J Antibiot; 1980 Aug; 33(8):758-66. PubMed ID: 6937692
    [No Abstract]   [Full Text] [Related]  

  • 38. [Recent development of beta-lactam drugs (author's transl)].
    Kuwahara S
    Nihon Saikingaku Zasshi; 1979 Sep; 34(5):713-30. PubMed ID: 392125
    [No Abstract]   [Full Text] [Related]  

  • 39. [Laboratory and clinical studies on cefmetazole].
    Peng CF; Lin YT; Chiou JJ; Kuo CS; Lin SR
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1986 Apr; 2(4):290-4. PubMed ID: 3482896
    [No Abstract]   [Full Text] [Related]  

  • 40. [Experimental and clinical studies on cefmetazole in the field of internal medicine].
    Hiraoka T; Kuwabara M; Nakamura M; Imagawa M; Ishida M; Fujiue Y; Muroki K; Ikeda M
    Jpn J Antibiot; 1985 Feb; 38(2):235-43. PubMed ID: 3859674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.